Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn(TM) Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination

Stock Information for Natural Alternatives International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Natural Alternatives International Inc.

Natural Alternatives International, Inc. Announces 2026 Q1 Results
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.